{"id":"W2049143320","doi":"10.1111/j.1365-2036.2006.02748.x","title":"Treating chronic hepatitis C with pegylated interferon alfa‐2a (40 KD) and ribavirin in clinical practice","year":2006,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Hepatitis C virus research","field":"Medicine","cited_by":71,"is_retracted":false,"has_abstract":true,"ca_institutions":"Roche (Canada); Toronto Western Hospital; Toronto General Hospital; University Health Network; Royal Victoria Hospital; Vancouver Hospital and Health Sciences Centre; BC Centre for Disease Control; Queen Elizabeth II Health Sciences Centre; University of Alberta; University of Calgary","funders":"F. Hoffmann-La Roche","keywords":"Ribavirin; Medicine; Internal medicine; Pegylated interferon; Adverse effect; Gastroenterology; Clinical trial; Randomized controlled trial; Hepatitis C; Cirrhosis; Hepatitis C virus; Immunology; Virus","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007521319,0.0003659361,0.0009714058,0.000710124,0.0005593112,0.001009771,0.0007873158,0.001996588,0.002559024],"category_scores_gemma":[0.02247072,0.0002960045,0.0003569769,0.001064795,0.0009344786,0.000858804,0.001003797,0.0009262485,0.0005471866],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000877429,"about_ca_system_score_gemma":0.003547666,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006378256,"about_ca_topic_score_gemma":0.0008531513,"domain_scores_codex":[0.9929899,0.004968475,0.0006563918,0.000469794,0.0007107933,0.0002045974],"domain_scores_gemma":[0.9858816,0.005116808,0.005049759,0.0003797149,0.001041969,0.002530208],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.0176145,0.005593394,0.06094926,0.006207485,0.0003158499,0.0007153238,0.0008062312,0.001044035,0.002740594,0.0004801314,0.008824546,0.8947086],"study_design_scores_gemma":[0.1303082,0.1436358,0.5621179,0.02023536,0.002270078,0.01273286,0.003160294,0.00514357,0.003878297,0.008072222,0.1081706,0.0002748992],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.7842832,0.1704163,0.002923428,0.02359367,0.0007953861,0.003809848,0.0001888275,0.0001661987,0.01382323],"genre_scores_gemma":[0.9119531,0.06090648,0.01449864,0.006293832,0.001805074,0.003341407,0.0003609727,0.00001423899,0.0008262125],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007521319,"threshold_uncertainty_score":0.03977698,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03742171039494784,"score_gpt":0.410042578304414,"score_spread":0.3726208679094661,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}